Alithea Genomics has secured $6.9 million in a seed funding round to advance its technology for industrial-scale RNA sequencing. The company's platform aims to accelerate primary drug screening and toxicology assessments. This funding will support the expansion of their capabilities in this critical area of pharmaceutical research.